Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| hypervascularity prostate |
|
Prostate cancer treatment, prostate cancer brachytherapy - dattoli.com prostate cancer treatment,Non-Surgical Prostate Cancer Treatment Center is a blood flow or hypervascularity as findings consistent with malignancy. The role of color Doppler and staging biopsies in prostate cancer The role of color Doppler and staging biopsies in prostate cancer detection. the mid 1990s onward can define areas of hypervascularity in the prostate. Ultrasound Quarterly - Fulltext: Volume 17(3) September 2001 p 185 Color Doppler Imaging of the Prostate: Important Adjunct to Endorectal that had asymmetric hypervascularity or areas of asymmetric flow, usually (Fig. PROSTATE CANCER DETECTION USING POWER DOPPLER IMAGING paid to the relationship between hypervascularity. and prostate cancer. Unfortunately, several studies. concluded that color Doppler imaging had little ad- Peripheral Hypoechoic Lesions of the Prostate: Evaluation with It is known that the lesion in prostate cancer usually has hypervascularity 7, and CDUS/PDUS may be of help in differentiating prostate cancer from benign Hematology/Oncology Clinics of North America : New Clinical Benign prostate hypertrophy (BPH) is often hypervascular and mimics the appearance of prostate cancer on cD US; therefore, transitional zone prostate cancer Blackwell Synergy - BJU Int, Volume 100 Issue 6 Page 1264-1267 These agents provide clear enhancement of the Doppler signal from human prostate. In the present series CEUS was used in hypervascular areas in the IngentaConnect Visualization of prostate cancer using dynamic In conclusion, both transrectal PDUS and DCE-MRI can be used to demonstrate hypervascularity in many prostate cancers. DCE-MRI was significantly more Melorheostosis: Follow-up of a case Compounded with carcinoma Carcinoma of the prostate is usually spheroidal-celled, with a varying degree Previous authors have suggested hypervascularity as a causative factor in Prostate: High-Frequency Doppler US Imaging for Cancer Detection We did not attempt to analyze the patterns of hypervascularity visualized in the prostate prospectively. On the basis of pathologic findings, Prostate Carcinoma Doppler ultrasound shows a hypervascular lesion representing prostate cancer at the right mid-gland with a high color pixel density. b Clinical evaluation of transrectal power Doppler imaging in the ings may render the indication for prostate biopsy. more accurate for patients with intermediate PSA. Brawer et al. 26 found that hypervascularity KoreaMed - Basic Search The presence of hypoechoic lesion on transrectal sonography and hypervascularity on color/power Doppler sonography in the peripheral zone of the prostate Correlation between prostate cancer grade and vascularity on color demonstrated that focal hypervascularity in the. peripheral zone on color Doppler imaging was as-. sociated with an increased likelihood of prostate eMedicine - Prostate Carcinoma : Article by Richard Clements Focal areas of hypervascularity in the PZ of the isoechoic prostate, as shown on color Doppler examination, may also be targeted. Visualization of prostate cancer using dynamic contrast-enhanced Hypervascularity in prostate cancer has also been demonstrated using transrectal colour or power Doppler ultrasound, and the distribution of Doppler signals Color and Power Doppler Sonography in the Diagnosis of Prostate Previous reports based on qualitative assessment suggest that hypervascularity increases likelihood of prostate cancer. Our objective was to compare 2 Endorectal Color Doppler Sonography and Endorectal MR Imaging following four features: hypervascularity, prostate-specific antigen level greater than 20 ng/mL,. three or more sextants of the gland having positive Endorectal Color Doppler Sonography and Endorectal MR Imaging The 42 hypervascular tumors were hypoechoic in every case and had a had the following four features: hypervascularity, prostate-specific antigen level |
| hypervascularity prostate |
|
natural prostate reducer vitamin milking prostate otrivin prostate pictures prostate g spot |